Clinical Trial Update: Seravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis

View source ↗

Summary

A validation study is planned to evaluate Seravue for diagnosing hepatocellular carcinoma, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Seravue

Snippet

Sponsor: ImCare Biotech | Conditions: Hepatic Cancer | Status: NOT_YET_RECRUITING